Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL130702 | Predictors of de novo development of obstructive sleep apnea in pregnancy | 1 | 2020 |
| R01HL133113 | Complementopathies: Genotype and Phenotype | 1 | 2020 |
| R01HL135001 | Functional roles of human pulmonary DC's in the lung draining lymph nodes | 1 | 2020 |
| R01HL135093 | Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy | 1 | 2020 |
| R01HL138749 | The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity | 1 | 2020 |
| R01HL139448 | Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT | 1 | 2020 |
| R01MH110246 | Dysregualtion of gliotransmission in models of neuroHIV | 1 | 2020 |
| R01MH110259 | Neuroimmune mechanisms of depression in adults with HIV infection | 1 | 2020 |
| R01MH110921 | Molecular Profiling of Schizophrenia | 1 | 2020 |
| R01NS096246 | Molecular Mechanisms and Functions of Mitochondrial Ca2+ transport in Neurons | 1 | 2020 |
| R01OD023138 | Immunodeficient Pigs for Stem Cell-Based Regenerative Medicine | 1 | 2020 |
| R21DE028690 | Breaching the Epithelial Lining for Effective Salivary Gland Stem Cell Delivery in Clinical-Relevant Settings | 1 | 2020 |
| R21HL147401 | Mitochondrial Genetic Alterations: A clinical trial of a standardized research e-cigarette | 1 | 2020 |
| R21MH121959 | Chronic stress, complement immune system and behavior | 1 | 2020 |
| R21NS111255 | Role of the Sez6 family in synapse pruning | 1 | 2020 |
| R21OD027062 | Germ cell preservation of immunodeficient pigs utilizing embryo complementation approach | 1 | 2020 |
| R24DK082841 | Integrated Systems Biology Approach to Diabetic Microvascular Complications | 1 | 2020 |
| R35CA197743 | Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment | 1 | 2020 |
| R50CA211482 | Immunogenomic analytical approaches for research and clinical applications | 1 | 2020 |
| R50CA221808 | Discovery and Validation of Biomarkers for Early Cancer Detection Using Mass Spectrometry | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=40